U.S. Markets closed
  • S&P 500

    3,269.96
    -40.15 (-1.21%)
     
  • Dow 30

    26,501.60
    -157.51 (-0.59%)
     
  • Nasdaq

    10,911.59
    -274.00 (-2.45%)
     
  • Russell 2000

    1,538.48
    -23.10 (-1.48%)
     
  • Crude Oil

    35.72
    -0.45 (-1.24%)
     
  • Gold

    1,878.80
    +10.80 (+0.58%)
     
  • Silver

    23.72
    +0.35 (+1.52%)
     
  • EUR/USD

    1.1641
    -0.0037 (-0.3143%)
     
  • 10-Yr Bond

    0.8600
    +0.0250 (+2.99%)
     
  • Vix

    38.02
    +0.43 (+1.14%)
     
  • GBP/USD

    1.2953
    +0.0030 (+0.2319%)
     
  • USD/JPY

    104.6350
    +0.0250 (+0.0239%)
     
  • BTC-USD

    13,749.02
    -77.29 (-0.56%)
     
  • CMC Crypto 200

    265.42
    +1.78 (+0.68%)
     
  • FTSE 100

    5,577.27
    -4.48 (-0.08%)
     
  • Nikkei 225

    22,977.13
    -354.81 (-1.52%)
     

New Strong Sell Stocks for September 10th

Zacks Equity Research
·1 min read

Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today:

Shinhan Financial Group Co., Ltd. SHG is a provider of financial products and services. The Zacks Consensus Estimate for its current year earnings has been revised 10.5% downward over the last 30 days.

AZZ Inc. AZZ is a provider of galvanizing and metal coating solutions, welding solutions, specialty electrical equipment, and highly engineered services to the power generation, transmission, distribution, refining, and industrial markets. The Zacks Consensus Estimate for its current year earnings has been revised 22.2% downward over the last 30 days.

Chiasma, Inc. CHMA is a clinical late-stage biopharmaceutical company. The Zacks Consensus Estimate for its current year earnings has been revised 18.6% downward over the last 30 days.

Mesa Laboratories, Inc. MLAB is a designer and manufacturer of quality control instruments and disposable products. The Zacks Consensus Estimate for its current year earnings has been revised 26.4% downward over the last 30 days.

Itamar Medical Ltd. ITMR is engaged in research, development and leasing of non-invasive medical devices for the cardiology market. The Zacks Consensus Estimate for its current year earnings has been revised 18.4% downward over the last 30 days.

View the entire Zacks Rank #5 List.


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
AZZ Inc. (AZZ) : Free Stock Analysis Report
 
Shinhan Financial Group Co Ltd (SHG) : Free Stock Analysis Report
 
Mesa Laboratories, Inc. (MLAB) : Free Stock Analysis Report
 
Chiasma, Inc. (CHMA) : Free Stock Analysis Report
 
Itamar Medical Ltd. Sponsored ADR (ITMR) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.